IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAF5. A total of 19 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $6,265,000 | +0.7% | 5,300,000 | 0.0% | 0.59% | -11.8% |
| Q2 2021 | $6,220,000 | +6.0% | 5,300,000 | 0.0% | 0.67% | -7.0% |
| Q1 2021 | $5,870,000 | -1.5% | 5,300,000 | 0.0% | 0.72% | +8.0% |
| Q4 2020 | $5,961,000 | -23.1% | 5,300,000 | -32.1% | 0.66% | -30.0% |
| Q3 2020 | $7,747,000 | – | 7,800,000 | – | 0.95% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opti Capital Management, LP | 5,300,000 | $5,870,000 | 0.72% |
| SHENKMAN CAPITAL MANAGEMENT INC | 4,355,000 | $4,850,000 | 0.57% |
| AQR Arbitrage LLC | 7,700,000 | $8,532,000 | 0.31% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 10,416,000 | $11,544,000 | 0.30% |
| LINDEN ADVISORS LP | 26,849,000 | $29,850,000 | 0.22% |
| WOLVERINE ASSET MANAGEMENT LLC | 21,227,000 | $23,520,000 | 0.20% |
| Jefferies Group LLC | 5,218,000 | $5,823,079 | 0.05% |
| HBK INVESTMENTS L P | 10,000,000 | $11,104,000 | 0.05% |
| Calamos Advisors LLC | 7,500,000 | $8,314,000 | 0.04% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 8,000,000 | $8,865,000 | 0.03% |